https://www.remynd.com/news-2/in-memoriam%3A-johan-cardoen-(1958-2025) 2025-12-19 https://www.remynd.com/news-2/lessons-from-our-phase-2a-alzheimer%E2%80%99s-septin-trial 2025-09-12 https://www.remynd.com/news-2/alzheimer%E2%80%99s-pipeline-featured-on-vrt-nws-and-radio-1 2025-07-10 https://www.remynd.com/news-2/minister-jan-jambon-visits-remynd 2025-05-28 https://www.remynd.com/news-2/news-title-01 2025-05-06 https://www.remynd.com/news-2/remynd-announces-appointment-floor-stam-johan-cardoen 2025-05-06 https://www.remynd.com/news-2/remynd-announces-positive-phase-2a-clinical-trial-results 2025-05-07 https://www.remynd.com/news-2/remynd-announces-strategic-transition 2025-05-06 https://www.remynd.com/news-2/unlearn-and-remynd-partner 2025-05-08 https://www.remynd.com/news-2/remynd-tests-optimized-septin-modulator-against-alzheimers-disease-in-phase-1-clinical-trial 2025-05-07